1. Home
  2. Stocks
  3. Emmessa Share Price

Emmessar Biotech & Nutrition Share Price

Small Cap

₹52.18 +8.69 (19.98%)

05 Nov, 2024 20:56

SIP TrendupStart SIP in EMMESSA

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 28.05%
  • Over 3 Month + 14.93%
  • Over 6 Month + 32.87%
  • Over 1 Year + 116.51%
SIP Lightning

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Emmessar Biotech & Nutrition Financial

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹52.18
+ 8.69 (19.98%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹44.81
  • 50 Day
  • ₹43.74
  • 100 Day
  • ₹42.30
  • 200 Day
  • ₹39.16

Resistance and Support

48.8 Pivot Speed
  • R3 65.71
  • R2 58.95
  • R1 55.56
  • S1 45.41
  • S2 38.65
  • S3 35.26

Is Emmessar Biotech & Nutrition Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.57 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 146% is great, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -19% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-03 Quarterly Results
2023-12-09 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
37.48%
2.8%
  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹52 As on 05 November, 2024 | 20:42

The Market Cap of Emmessar Biotech & Nutrition is ₹26.1 Cr As on 05 November, 2024 | 20:42

The P/E ratio of Emmessar Biotech & Nutrition is 33.3 As on 05 November, 2024 | 20:42

The PB ratio of Emmessar Biotech & Nutrition is 3.5 As on 05 November, 2024 | 20:42

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.